ArticleExperimental hematology & oncology2025

Development of a bispecific antibody-drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors.

Meiying Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.